AgomAb Therapeutics NV (AGMB)
AGMB trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$8.81
-3.08% on the day
Market cap
$433.9M
Small cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | AGMB on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | Belgium |
| IPO year | 2026 |
| SEC CIK | 0002020932 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | C9 |
Financials
Foreign filer: no machine-readable annual figure in SEC data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B4 | 2026-02-06 |
| Latest annual report FORM 20-F | 20-F | 2026-04-23 |
| Latest quarterly / interim FORM 6-K | 6-K | 2026-10-13 |
Source: SEC EDGAR submissions feed, 47 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -0.6% |
| 1 month | -28.0% |
| 3 months | -29.0% |
| Year to date | Not enough price history |
| 1 year | Not enough price history |
| From 52-week high | -50.9% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ENTX | Entera Bio Ltd. | $2.49 | -6.04% | $433.1M |
| AUTL | Autolus Therapeutics plc American Depositary Share | $1.62 | -6.90% | $431.2M |
| ALLO | Allogene Therapeutics Inc. | $1.29 | -7.86% | $445.7M |
| TECX | Tectonic Therapeutic Inc. | $21.31 | -4.65% | $416.6M |
| ZURA | Zura Bio Limited | $4.23 | +5.75% | $405.4M |
| PROK | ProKidney Corp. | $1.57 | -5.99% | $474.6M |
| RGNX | REGENXBIO Inc. | $7.26 | -6.56% | $479.3M |
| EDIT | Editas Medicine Inc. | $2.44 | -11.09% | $375.5M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier